Skip to main content
2024 DSPN Spine Summit Main banner
Back

Anthony L. Asher, MD (he/him/his)

Clinical Professor
Neuroscience Institute, Carolina Neurosurgery & Spine Associates
Charlotte, NC, US

Anthony L. Asher, MD, FAANS, FACS is President and Service Line Leader, Neuroscience Insititute, Atrium-Wake Forest Baptist Health; Interim Chairman, Department of Neurological Surgery, Carolinas Medical Center; recent past Director of the Neurosurgery Residency Training Program at Carolinas Medical Center; and Director, Adult NeuroOncology Program, Levine Cancer Institute. He is a Clinical Professor of Neurosurgery at the University of North Carolina Chapel Hill, Carolinas Medical Center, Wake Forest SOM and Vanderbilt University School of Medicine.

Dr. Asher was awarded one of the original Howard Hughes Medical Institute-National Institutes of Health (NIH) Research Scholarships. He amplified his basic and translational research training as a Fellow at Surgery Branch of the National Cancer Institute (NCI), NIH. His laboratory research has focused on cellular cancer immunotherapy.

Since the completion of his neurosurgery residency training at the University of Michigan, Dr. Asher has been a member of the Charlotte, NC based Carolina Neurosurgery and Spine Associates (CNSA), one of the nation’s largest and most respected practices. His his primary clinical interests include neuro-oncology, skull-base surgery, stereotactic surgery, trigeminal neuralgia and minimally invasive spine surgery.

Dr. Asher has served in numerous senior national leadership positions, including President, Congress of Neurological Surgeons (CNS), Vice Chairman of the American Board of Neurological Surgery (ABNS), and Treasurer, American Association of Neurological Surgeons (AANS). He is curently President-Elect, AANS. He is Past Chairman of the Central Nervous System Organ Site Committee of the American College of Surgeons Oncology Group.

Dr. Asher has extensive experience developing and conducting phase 1-4 cooperative clinical cancer research programs. He and his colleauges have developed novel treatment paradigms for patients with metastatic brain cancer which have now become standard of care in a majority of North American treatment environments. He is author or co-author of over 200 peer-reviewed manuscripts and book chapters.

Dr. Asher has extensive leadership experience in surgical quality improvement. He has developed and directed several unprecedented national cooperative clinical databases in neurosurgery and related fields including the Quality and Outcomes Database (QOD), the American Spine Registry, and ABNS POST, the latter serving as the primary clinical data resource supporting the process of ABNS primary board certification. He has represented neurosurgery and other medical specialties in leadership and advisory roles to the AMA’s National Quality Registry Council, the National Quality Forum (NQF), The Institute for Healthcare Improvement, the Joint Commission, the FDA, and the HHS Secretary’s Advisory Committee on Human Research Protections.

Dr. Asher has performed significant work with bio-industry, and has served as Chief Medical Officer to Hyperbranch Medical Technologies, along with consultant to Medtronic, Globus, Stryker, along with other organizations.

Dr. Asher has led the development of several novel programs in neurosurgical education including the CNS Neurosurgical Forum, Integrated Medical Learningsm, AANS Envision, and the Self Assessment in Neurological Surgery (SANS), the latter of which has become an integral component of the ABNS’ Maintenance of Certification and Written Examination Programs.

Asher is recognized internationally for his development of advanced treatment paradigms, clinical research, educational programs, care innovation, and organizational leadership.

Disclosure(s): No financial relationships to disclose

Presentation(s):